Betker Jamie L, Anchordoquy Thomas J
Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado 80045.
Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado 80045.
J Pharm Sci. 2017 Mar;106(3):872-881. doi: 10.1016/j.xphs.2016.11.013. Epub 2016 Nov 22.
Repetitive administration is routinely used to maintain therapeutic drug levels, but previous studies have documented an accelerated blood clearance of some lipid-based delivery systems under these conditions. To assess the effect of repetitive administration, non-PEGylated lipoplexes (+/-0.5) were administered 4 times via tail vein injection at 3-day intervals to immunocompetent BALB/c mice bearing 4T1 tumors. This study measured the effect of repeat administration of nontargeted lipoplexes on clearance, cytokine/chemokine response, plasmid distribution, reporter gene expression, and liver toxicity. We do not observe a refractory period or a statistically significant difference in blood clearance between the first administration and subsequent injections of this lipoplex formulation, consistent with the absence of a cytokine/chemokine response. However, we do see a significant effect on both plasmid accumulation and expression, an enhancement of 26-fold and 10-fold in tumor plasmid levels and expression, respectively, after 4 injections as compared to that after a single injection. In addition, in vivo imaging suggests that expression in other organs had diminished rapidly 72 h after each administration, in contrast to relatively constant expression in the tumor. Taken together, the findings indicate that gene delivery to tumors can be dramatically enhanced by employing repetitive administration.
重复给药通常用于维持治疗药物水平,但先前的研究已证明在这些条件下一些基于脂质的递送系统的血液清除加速。为了评估重复给药的效果,将非聚乙二醇化脂质体(+/-0.5)以3天的间隔通过尾静脉注射对携带4T1肿瘤的免疫活性BALB/c小鼠进行4次给药。本研究测量了非靶向脂质体重复给药对清除率、细胞因子/趋化因子反应、质粒分布、报告基因表达和肝毒性的影响。我们没有观察到该脂质体制剂首次给药与后续注射之间的不应期或血液清除率的统计学显著差异,这与细胞因子/趋化因子反应的缺乏一致。然而,我们确实看到对质粒积累和表达都有显著影响,与单次注射后相比,4次注射后肿瘤质粒水平和表达分别提高了26倍和10倍。此外,体内成像表明,每次给药后72小时,其他器官中的表达迅速下降,这与肿瘤中相对恒定的表达形成对比。综上所述,研究结果表明,采用重复给药可显著增强基因向肿瘤的递送。